The Role of Interleukin-6 as an Indicator of Multiple Sclerosis Progression From Relapse Remitting to Secondary Progressive Status

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

Eslami Mina; MIRABI ARAZ MOHAMMAD; Baghbanian Mohammad; RAFIEI ALIREZA

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Research in Molecular Medicine Year:2020 | Volume:8 | Issue:1 Page(s): 1-7

Download Full-Text

View:

157

Download:

Cites:

Information Journal Paper

Title

The Role of Interleukin-6 as an Indicator of Multiple Sclerosis Progression From Relapse Remitting to Secondary Progressive Status

Author(s)

Eslami Mina | MIRABI ARAZ MOHAMMAD | Baghbanian Mohammad | RAFIEI ALIREZA | Issue Writer Certificate

Keywords

Multiple Sclerosis

Interleukin-6 (IL-6)

Interleukin-8 (IL-8)

25-Hydroxyl vitamin D3

Clinical symptoms

Secondary progressive MS (SPMS)

Relapsing remitting MS (RRMS)

Abstract

Background: Multiple Sclerosis (MS) is the most common chronic inflammatory disease of the white matter of the Central Nervous System (CNS). Proinflammatory cytokine network such as interleukin-6 (IL-6) has a role in the initiation of a destructive immune response in CNS and the progression of the disease. This study aimed to evaluate the comparative levels of IL-6 and IL-8 in MS patients and healthy controls and also to assess any fluctuation in IL-6 and IL-8 levels in MS progression. Materials and Methods: This case-control study recruited a total of 183 subjects, including 103 MS patients and 80 sex-and age-matched healthy controls. MS patients included 51 Relapsing Remitting MS (RRMS), 25 secondary progressive MS (SPMS), 27 Primary Progressive MS (PPMS), and Progressive Relapsing MS (PRMS). Clinical findings were collected, and serum levels of IL-6, IL-8, and 25-Hydroxyl vitamin D3 (25(OH)D3) were determined with ELISA. Results: The mean serum level of IL-6 was significantly higher in MS patients than healthy controls (23. 8± 2. 1 vs. 15. 6± 2. 7 pg/mL, P=0. 043). MS patients with SPMS had more prominent IL-6 levels than RRMS or PPMS (P=0. 008). However, IL-8 levels did not show a significant change either in the patients compared with the controls or in the different forms of MS. MS was more prone to progressive form in male patients. Mean 25(OH)D3 level was significantly lower in MS patients than the controls. Meanwhile, the mean 25(OH)D3 level was surprisingly higher in MS patients with SPMS. Conclusion: The increased serum level of IL-6 in more advanced MS status, SPMS, suggests that IL-6 but not IL-8 might be a prognostic marker for the disease deterioration. Besides, the tendency for MS to progress to worse stages in affected men is an important finding that needs further clarification.

Cites

No record.

References

Cite

APA: Copy

Eslami, Mina, MIRABI, ARAZ MOHAMMAD, Baghbanian, Mohammad, & RAFIEI, ALIREZA. (2020). The Role of Interleukin-6 as an Indicator of Multiple Sclerosis Progression From Relapse Remitting to Secondary Progressive Status. RESEARCH IN MOLECULAR MEDICINE, 8(1), 1-7. SID. https://sid.ir/paper/687361/en

Vancouver: Copy

Eslami Mina, MIRABI ARAZ MOHAMMAD, Baghbanian Mohammad, RAFIEI ALIREZA. The Role of Interleukin-6 as an Indicator of Multiple Sclerosis Progression From Relapse Remitting to Secondary Progressive Status. RESEARCH IN MOLECULAR MEDICINE[Internet]. 2020;8(1):1-7. Available from: https://sid.ir/paper/687361/en

IEEE: Copy

Mina Eslami, ARAZ MOHAMMAD MIRABI, Mohammad Baghbanian, and ALIREZA RAFIEI, “The Role of Interleukin-6 as an Indicator of Multiple Sclerosis Progression From Relapse Remitting to Secondary Progressive Status,” RESEARCH IN MOLECULAR MEDICINE, vol. 8, no. 1, pp. 1–7, 2020, [Online]. Available: https://sid.ir/paper/687361/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops